About the Study
Coronaviruses (CoVs) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as SARS and MERS. A pneumonia of unknown cause was detected in Wuhan, China in December 2019. The 2019-nCoV causes illness ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS), which can spread from person-to-person. The CDC believes that symptoms may appear in as few as 2 days or as long as 14 days after exposure. Common symptoms include a fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe respiratory issues, kidney failure and even death.
There is currently no vaccine to protect against COVID-19, nor any specific antiviral treatment. The best way to prevent the infection is to avoid being exposed to the virus until a vaccine is available. There is an urgent public health need for rapid development of a COVID-19 vaccine to help prevent the spread of the disease. This study will evaluate the safety and efficacy of a COVID-19 vaccine.
The study will last approximately 25 months with 8 visits to our office. Compensation is available for time and travel up to $1,125.00, for those who qualify. Study related care is available to participants at no cost and health insurance is not required nor needed.
- Over the age of 18 years old and are at high risk of COVID-19 infection
- No known history of COVID-19 infection
- No history of anaphylaxis reaction of a vaccine
- Please note, other conditions may apply.